• Alter HJ & Seeff LB (2000) Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome. Seminars in Liver Disease 20, 1735.
  • Alter HJ, Purcell RH, Shih JW et al. (1989) Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. New England Journal of Medicine 321, 14941500.
  • Alter MJ, Kuhnert WL & Finelli L (2003) Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention. MMWR. Recommendations and Reports 52(RR-3), 113, 15; quiz CE1-4.
  • Ampofo W, Nii-Trebi N, Ansah J et al. (2002) Prevalence of blood-borne infectious diseases in blood donors in Ghana. Journal of Clinical Microbiology 40, 35233525.
  • Esteban JI, Gonzalez A, Hernandez JM et al. (1990) Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis. New England Journal of Medicine 323, 11071112.
  • Etard JF, Colbachini P, Dromigny JA & Perrier-Gros-Claude JD (2003) Hepatitis C antibodies among blood donors, Senegal, 2001. Emerging Infectious Disease 9, 14921493.
  • Fang CT, Field SP, Busch MP & Heyns Adu P (2003) Human immunodeficiency virus-1 and hepatitis C virus RNA among South African blood donors: estimation of residual transfusion risk and yield of nucleic acid testing. Vox Sanguinis 85, 919.
  • Global Surveillance and Control of Hepatitis C (1999) Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. Journal of Viral Hepatitis 6, 3547.
  • Schreiber GB (1996) The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study (see comments). New England Journal of Medicine 334, 16851690.
  • Tess BH, Levin A, Brubaker G et al. (2000) Seroprevalence of hepatitis C virus in the general population of northwest Tanzania. American Journal of Tropical Medicine and Hygiene 62, 138141.